Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Empros Pharma AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 More Arrow 1 Less Arrow 0
Earnings before taxes -7,556 More Arrow -6,938 More Arrow -6,132
EBITDA -7,862 More Arrow -7,850 More Arrow -6,156
Total assets 84,153 More Arrow 98,915 Less Arrow 51,230
Current assets 5,170 More Arrow 22,559 Less Arrow 5,269
Current liabilities 699 More Arrow 4,791 Less Arrow 3,191
Equity capital 83,454 More Arrow 94,124 Less Arrow 48,039
- share capital 169 Less Arrow 121 Less Arrow 104
Employees (average) 8 Equal arrow 8 Less Arrow 7

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 99.2% Less Arrow 95.2% Less Arrow 93.8%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -9.0% More Arrow -7.0% Less Arrow -12.0%
Current ratio 739.6% Less Arrow 470.9% Less Arrow 165.1%
Return on equity (ROE) -9.1% More Arrow -7.4% Less Arrow -12.8%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 14% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.